Literature DB >> 31806405

Passion fruit-like exosome-PMA/Au-BSA@Ce6 nanovehicles for real-time fluorescence imaging and enhanced targeted photodynamic therapy with deep penetration and superior retention behavior in tumor.

Shaojun Pan1, Lijia Pei2, Amin Zhang3, Yuhui Zhang4, Chunlei Zhang3, Mark Huang3, Zhicheng Huang3, Bin Liu3, Lirui Wang3, Lijun Ma5, Qian Zhang6, Daxiang Cui7.   

Abstract

Exosomes (Exos) of approximately 30-150 nm in diameters are the promising vehicles for therapeutic drugs. However, several challenges still exist in clinical applications, such as unsatisfied yield of exosomes, complicated labeling procedure and low drug loading efficiency. In this work, the gram-scale amount of high-purity urinary exosomes can be obtained from gastric cancer patients by non-invasive method. Passion fruit-like Exo-PMA/Au-BSA@Ce6 nanovehicles were fabricated by considerable freshly-urinary Exos loaded efficiently with multi-functionalized PMA/Au-BSA@Ce6 nanoparticles via instant electroporation strategy. In this system, prepared Exo-PMA/Au-BSA@Ce6 nanovehicles could be internalized into cancer cells effectively, and could delay the endocytosis of macrophages and prolong blood circulation time owing to its membrane structure and antigens. Under 633 nm laser irradiation and acidic condition, the structures of nanovehicles would be collapsed and tremendous PMA/Au-BSA@Ce6 nanoparticles could be released inside cancer cells, produced considerable singlet oxygen, inhibiting growth of tumor cells. In vivo experiment of MGC-803 tumor-bearing nude mice showed that prepared Exo-PMA/Au-BSA@Ce6 nanovehicles could target tumor cells with deep penetration and superior retention performance in tumors. This work reports a reliable conjugation-free labeling strategy for tracking exosomes harvested from human urine. Moreover, the integration of multifunctional nanoparticles with urinary Exos paves a versatile road for the development of cancer-targeted photodynamic therapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fluorescence imaging; Nanovehicles; Photodynamic therapy; Ultra-small gold nanoparticles; Urinary exosome

Mesh:

Substances:

Year:  2019        PMID: 31806405     DOI: 10.1016/j.biomaterials.2019.119606

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

1.  X-ray-Based Techniques to Study the Nano-Bio Interface.

Authors:  Carlos Sanchez-Cano; Ramon A Alvarez-Puebla; John M Abendroth; Tobias Beck; Robert Blick; Yuan Cao; Frank Caruso; Indranath Chakraborty; Henry N Chapman; Chunying Chen; Bruce E Cohen; Andre L C Conceição; David P Cormode; Daxiang Cui; Kenneth A Dawson; Gerald Falkenberg; Chunhai Fan; Neus Feliu; Mingyuan Gao; Elisabetta Gargioni; Claus-C Glüer; Florian Grüner; Moustapha Hassan; Yong Hu; Yalan Huang; Samuel Huber; Nils Huse; Yanan Kang; Ali Khademhosseini; Thomas F Keller; Christian Körnig; Nicholas A Kotov; Dorota Koziej; Xing-Jie Liang; Beibei Liu; Sijin Liu; Yang Liu; Ziyao Liu; Luis M Liz-Marzán; Xiaowei Ma; Andres Machicote; Wolfgang Maison; Adrian P Mancuso; Saad Megahed; Bert Nickel; Ferdinand Otto; Cristina Palencia; Sakura Pascarelli; Arwen Pearson; Oula Peñate-Medina; Bing Qi; Joachim Rädler; Joseph J Richardson; Axel Rosenhahn; Kai Rothkamm; Michael Rübhausen; Milan K Sanyal; Raymond E Schaak; Heinz-Peter Schlemmer; Marius Schmidt; Oliver Schmutzler; Theo Schotten; Florian Schulz; A K Sood; Kathryn M Spiers; Theresa Staufer; Dominik M Stemer; Andreas Stierle; Xing Sun; Gohar Tsakanova; Paul S Weiss; Horst Weller; Fabian Westermeier; Ming Xu; Huijie Yan; Yuan Zeng; Ying Zhao; Yuliang Zhao; Dingcheng Zhu; Ying Zhu; Wolfgang J Parak
Journal:  ACS Nano       Date:  2021-03-02       Impact factor: 15.881

Review 2.  Exosomes as Carriers for Drug Delivery in Cancer Therapy.

Authors:  Weiping Zeng; Zhengbo Wen; Honglin Chen; Yuyou Duan
Journal:  Pharm Res       Date:  2022-03-29       Impact factor: 4.200

Review 3.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 4.  Non-Invasive imaging of extracellular vesicles: Quo vaditis in vivo?

Authors:  Dian R Arifin; Kenneth W Witwer; Jeff W M Bulte
Journal:  J Extracell Vesicles       Date:  2022-07

5.  Immune Checkpoint Inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles.

Authors:  Tian Tian; Ruyu Liang; Gulsah Erel-Akbaba; Lorenzo Saad; Pierre J Obeid; Jun Gao; E Antonio Chiocca; Ralph Weissleder; Bakhos A Tannous
Journal:  ACS Nano       Date:  2022-01-31       Impact factor: 18.027

Review 6.  Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).

Authors:  Hang Su; Weihong Ren; Dai Zhang
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 3.984

Review 7.  Recent advances in innovative strategies for enhanced cancer photodynamic therapy.

Authors:  Tingting Hu; Zhengdi Wang; Weicheng Shen; Ruizheng Liang; Dan Yan; Min Wei
Journal:  Theranostics       Date:  2021-01-15       Impact factor: 11.556

Review 8.  Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research.

Authors:  Giorgia Ailuno; Sara Baldassari; Francesco Lai; Tullio Florio; Gabriele Caviglioli
Journal:  Cells       Date:  2020-12-01       Impact factor: 6.600

9.  BSA-Stabilized Mesoporous Organosilica Nanoparticles Reversed Chemotherapy Resistance of Anaplastic Thyroid Cancer by Increasing Drug Uptake and Reducing Cellular Efflux.

Authors:  Xiao Han; Xiaoquan Xu; Yuxia Tang; Feipeng Zhu; Ying Tian; Wei Liu; Doudou He; Guangming Lu; Yunfei Gu; Shouju Wang
Journal:  Front Mol Biosci       Date:  2020-12-03

Review 10.  Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration.

Authors:  Zimu Li; Xiaoting Shan; Zhidong Chen; Nansha Gao; Wenfeng Zeng; Xiaowei Zeng; Lin Mei
Journal:  Adv Sci (Weinh)       Date:  2020-11-27       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.